Guy Wendy 4

What Happened
Guy Wendy, Chief Administrative Officer of Processa Pharmaceuticals (PCSA), acquired 2,436 shares on 2026-06-30 at $1.93 per share, a purchase totaling about $4,701. The transaction is coded as a purchase (P) on the Form 4 and was reported to the SEC.

Key Details

• Transaction date and price: 2026-06-30 — 2,436 shares at $1.93 each.
• Total transaction value: approximately $4,701.
• Transaction type: Open-market purchase (Form 4 code P).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Filing timeliness: Report filed 2026-07-01 (within the Form 4 two-business-day reporting window).
• No footnotes, 10b5-1 plan notation, tax withholding, or other qualifiers were noted in the information provided.

Context
Purchases by executives can be interpreted as a personal investment in the company, though small dollar-value buys (like this ~$4.7k purchase) may be routine and not materially informative on their own. This summary sticks to the facts reported on the Form 4 without inferring motive.